Cabaletta Bio (CABA) Capital Expenditures Growth (1y) (2020 - 2025)
Cabaletta Bio (CABA) Capital Expenditures Growth (1y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cabaletta Bio |
151.84 Mn |
18.24 Mn |
- |
-372.34% |
| Date | Value |
|---|
| Dec 31, 2025 |
-372.34% |
| Sep 30, 2025 |
-32.81% |
| Jun 30, 2025 |
114.98% |
| Dec 31, 2024 |
88.00% |
| Sep 30, 2024 |
2,146.15% |
| Jun 30, 2024 |
-603.51% |
| Mar 31, 2024 |
74.21% |
| Dec 31, 2023 |
109.36% |
| Sep 30, 2023 |
-96.22% |
| Jun 30, 2023 |
-78.81% |
| Mar 31, 2023 |
158.50% |
| Dec 31, 2022 |
-296.06% |
| Sep 30, 2022 |
520.78% |
| Jun 30, 2022 |
146.79% |
| Mar 31, 2022 |
-60.90% |
| Dec 31, 2021 |
380.18% |
| Sep 30, 2021 |
-352.47% |
| Jun 30, 2021 |
445.00% |
| Mar 31, 2021 |
66.37% |
| Dec 31, 2020 |
336.54% |
